Hostname: page-component-7c8c6479df-24hb2 Total loading time: 0 Render date: 2024-03-27T18:42:42.693Z Has data issue: false hasContentIssue false

DOES CLINICAL TRIAL SUBJECT SELECTION RESTRICT THE ABILITY TO GENERALIZE USE AND COST OF HEALTH SERVICES TO “REAL LIFE” SUBJECTS?

Published online by Cambridge University Press:  22 January 2003

Wendy A. Kennedy
Affiliation:
University of Montreal
Claudine Laurier
Affiliation:
University of Montreal
Jean-Luc Malo
Affiliation:
Hôpital du Sacré Coeur de Montréal
Heberto Ghezzo
Affiliation:
Meakins Christie Laboratories
Jocelyne L'archevêque
Affiliation:
Hôpital du Sacré Coeur de Montréal
André-Pierre Contandriopoulos
Affiliation:
University of Montreal

Abstract

Objectives: To explore one aspect of the external validity of the randomized controlled trial (RCT), specifically how being selected for inclusion in a trial and having participated has influenced the use and cost of asthma-related health services.

Methods: Services used by asthmatic users of inhaled corticosteroids (iCSTs) having previously participated in an RCT (TS, n = 46) were compared with individuals who had never participated (NS, n = 51).

Results: TS were more likely to use higher (≥400 μg) daily doses of iCSTs than NS (OR, 3.3; 95% CI, 1.1–8.3) but less likely to visit emergency departments (OR, 0.3; 95% CI, 0.1–0.7). Total asthma-related costs did not differ significantly.

Conclusions: Subject differences may impede generalizing from RCTs to real life.

Type
GENERAL ESSAYS
Copyright
© 2003 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)